These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17268548)

  • 1. Monoubiquitylation promotes mitochondrial p53 translocation.
    Marchenko ND; Wolff S; Erster S; Becker K; Moll UM
    EMBO J; 2007 Feb; 26(4):923-34. PubMed ID: 17268548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of p53 degradation via MDM2-mediated ubiquitylation and the ubiquitin-proteasome system during reperfusion after stroke: role of oxidative stress.
    Saito A; Hayashi T; Okuno S; Nishi T; Chan PH
    J Cereb Blood Flow Metab; 2005 Feb; 25(2):267-80. PubMed ID: 15678128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of ubiquitination in the direct mitochondrial death program of p53.
    Marchenko ND; Moll UM
    Cell Cycle; 2007 Jul; 6(14):1718-23. PubMed ID: 17630506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model.
    Becker K; Marchenko ND; Palacios G; Moll UM
    Cell Cycle; 2008 May; 7(9):1205-13. PubMed ID: 18418047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protosappanin B protects PC12 cells against oxygen-glucose deprivation-induced neuronal death by maintaining mitochondrial homeostasis via induction of ubiquitin-dependent p53 protein degradation.
    Zeng KW; Liao LX; Zhao MB; Song FJ; Yu Q; Jiang Y; Tu PF
    Eur J Pharmacol; 2015 Mar; 751():13-23. PubMed ID: 25657114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
    Lee JH; Kim HS; Lee SJ; Kim KT
    J Cell Sci; 2007 Jul; 120(Pt 13):2259-71. PubMed ID: 17591690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of HAUSP in vivo modulates p53 function.
    Kon N; Kobayashi Y; Li M; Brooks CL; Ludwig T; Gu W
    Oncogene; 2010 Mar; 29(9):1270-9. PubMed ID: 19946331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell death induced by 7-oxysterols via lysosomal and mitochondrial pathways is p53-dependent.
    Li W; Laskar A; Sultana N; Osman E; Ghosh M; Li Q; Yuan XM
    Free Radic Biol Med; 2012 Dec; 53(11):2054-61. PubMed ID: 22985798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The p53--Mdm2--HAUSP complex is involved in p53 stabilization by HAUSP.
    Brooks CL; Li M; Hu M; Shi Y; Gu W
    Oncogene; 2007 Nov; 26(51):7262-6. PubMed ID: 17525743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer.
    Ahn BY; Trinh DL; Zajchowski LD; Lee B; Elwi AN; Kim SW
    Oncogene; 2010 Feb; 29(8):1155-66. PubMed ID: 19935715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization.
    Li M; Chen D; Shiloh A; Luo J; Nikolaev AY; Qin J; Gu W
    Nature; 2002 Apr; 416(6881):648-53. PubMed ID: 11923872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HAUSP-regulated switch from auto- to p53 ubiquitination by Mdm2 (in silico discovery).
    Brazhnik P; Kohn KW
    Math Biosci; 2007 Nov; 210(1):60-77. PubMed ID: 17585950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperubiquitylation of wild-type p53 contributes to cytoplasmic sequestration in neuroblastoma.
    Becker K; Marchenko ND; Maurice M; Moll UM
    Cell Death Differ; 2007 Jul; 14(7):1350-60. PubMed ID: 17380154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
    Li M; Brooks CL; Wu-Baer F; Chen D; Baer R; Gu W
    Science; 2003 Dec; 302(5652):1972-5. PubMed ID: 14671306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2.
    Meulmeester E; Maurice MM; Boutell C; Teunisse AF; Ovaa H; Abraham TE; Dirks RW; Jochemsen AG
    Mol Cell; 2005 May; 18(5):565-76. PubMed ID: 15916963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy induces NEDP1-mediated destabilization of MDM2.
    Watson IR; Li BK; Roche O; Blanch A; Ohh M; Irwin MS
    Oncogene; 2010 Jan; 29(2):297-304. PubMed ID: 19784069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2.
    Stevenson LF; Sparks A; Allende-Vega N; Xirodimas DP; Lane DP; Saville MK
    EMBO J; 2007 Feb; 26(4):976-86. PubMed ID: 17290220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BARD1 BRCT domain contributes to p53 binding, cytoplasmic and mitochondrial localization, and apoptotic function.
    Tembe V; Martino-Echarri E; Marzec KA; Mok MT; Brodie KM; Mills K; Lei Y; DeFazio A; Rizos H; Kettle E; Boadle R; Henderson BR
    Cell Signal; 2015 Sep; 27(9):1763-71. PubMed ID: 26022179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HAUSP, a deubiquitinating enzyme for p53, is polyubiquitinated, polyneddylated, and dimerized.
    Lee HJ; Kim MS; Kim YK; Oh YK; Baek KH
    FEBS Lett; 2005 Aug; 579(21):4867-72. PubMed ID: 16111684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel defect in mitochondrial p53 accumulation following DNA damage confers apoptosis resistance in Ataxia Telangiectasia and Nijmegen Breakage Syndrome T-cells.
    Turinetto V; Porcedda P; Minieri V; Orlando L; Lantelme E; Accomasso L; Amoroso A; De Marchi M; Zannini L; Delia D; Giachino C
    DNA Repair (Amst); 2010 Nov; 9(11):1200-8. PubMed ID: 20947454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.